Prosecution Insights
Prosecution Insights
15 pending office actions • 12 clients • 15 examiners • 9 art units • 0 of 15 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (7%) |
| §103 only | 2 (13%) |
| §112 only | 1 (7%) |
| Multi-statute (no §101) | 11 (73%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MARCETICH, ADAM M | 1 | 72.6% | +18.8% |
| STRACHAN, KATE ELIZABETH | 1 | 45.5% | +30.9% |
| STEPHENS, AMELIA CAROLE | 1 | 80.0% | +50.0% |
| BYRD, EUGENE G | 1 | 69.8% | +9.6% |
| LEVY, BRANDON WILLIAM | 1 | 62.0% | +48.1% |
| MCEVOY, THOMAS M | 1 | 70.8% | +35.5% |
| GRASER, JENNIFER E | 1 | 76.5% | +23.6% |
| GONZALEZ, LUISALBERTO | 1 | 60.7% | +45.5% |
| OLYNICK, DAVID | 1 | 77.9% | +23.9% |
| MELHUS, BENJAMIN S | 1 | 60.0% | +44.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17625637 | TOGGLING VASCULAR ACCESS PORT | MARRISON, SAMUEL JOSEPH | 22d overdue |
| 18202051 | COMPOSITIONS FOR A DIETARY SUPPLEMENT TO MANAGE SENESCENT CELLS | GONZALEZ, LUISALBERTO | 13d |
| 18077847 | INFUSION APPARATUS WITH INFECTION BARRIER | LALONDE, ALEXANDRA ELIZABETH | 28d |
| 18032030 | VASCULAR ACCESS KIT | MELHUS, BENJAMIN S | 53d |
| 18373829 | SYSTEM AND METHODS TO ENHANCE CHEMOTHERAPY DELIVERY AND REDUCE TOXICITY | LEVY, BRANDON WILLIAM | 61d |
| 18827495 | DEVICES, SYSTEMS AND METHODS FOR THE BROAD-SPECTRUM REDUCTION OF PRO-INFLAMMATORY CYTOKINES IN BLOOD | MARCETICH, ADAM M | — |
| 18802722 | EXTRA-LUMEN ADSORPTION OF VIRAL PATHOGENS FROM BLOOD | STRACHAN, KATE ELIZABETH | — |
| 18652326 | COMPOSITIONS COMPRISING PROBIOTIC AND POSTBIOTIC STRAINS OF BACTERIA | STEPHENS, AMELIA CAROLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18232995 | Vector Transmitted Infectious Disease Assay | GRASER, JENNIFER E | 8d |
| 18202051 | COMPOSITIONS FOR A DIETARY SUPPLEMENT TO MANAGE SENESCENT CELLS | GONZALEZ, LUISALBERTO | 13d |
| 18032030 | VASCULAR ACCESS KIT | MELHUS, BENJAMIN S | 53d |
| 18373829 | SYSTEM AND METHODS TO ENHANCE CHEMOTHERAPY DELIVERY AND REDUCE TOXICITY | LEVY, BRANDON WILLIAM | 61d |
| 18827495 | DEVICES, SYSTEMS AND METHODS FOR THE BROAD-SPECTRUM REDUCTION OF PRO-INFLAMMATORY CYTOKINES IN BLOOD | MARCETICH, ADAM M | — |
| 18802722 | EXTRA-LUMEN ADSORPTION OF VIRAL PATHOGENS FROM BLOOD | STRACHAN, KATE ELIZABETH | — |
| 18652326 | COMPOSITIONS COMPRISING PROBIOTIC AND POSTBIOTIC STRAINS OF BACTERIA | STEPHENS, AMELIA CAROLE | — |
| 18277506 | VASCULAR OCCLUDER WITH INWARDLY INSERTABLE SEGMENT | MCEVOY, THOMAS M | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Portal Access, Inc. | 3 |
| Sigyn Therapeutics, Inc. | 2 |
| Iiaa Limited | 1 |
| Sealway AB | 1 |
| Sigyn Therapeutics | 1 |
| Venacore Inc. | 1 |
| Tick Off, LLC | 1 |
| Qualia Life Sciences LLC | 1 |
| Luna Health | 1 |
| Embrace Medical Ltd. | 1 |
| NV MEDTECH, Inc. | 1 |
| Curtin University | 1 |
| Art Unit | Apps |
|---|---|
| 3783 | 3 |
| 1645 | 2 |
| 3771 | 2 |
| 3675 | 1 |
| 3781 | 1 |
| 1624 | 1 |
| 3741 | 1 |
| 3791 | 1 |
| 1792 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18827495 | DEVICES, SYSTEMS AND METHODS FOR THE BROAD-SPECTRUM REDUCTION OF PRO-INFLAMMATORY CYTOKINES IN BLOOD | Sigyn Therapeutics, Inc. | MARCETICH, ADAM M | §103§112 | Non-Final OA | — | Pending | Sep 06, 2024 | |
| 18802722 | EXTRA-LUMEN ADSORPTION OF VIRAL PATHOGENS FROM BLOOD | Sigyn Therapeutics, Inc. | STRACHAN, KATE ELIZABETH | §102§103 | Non-Final OA | — | Pending | Aug 13, 2024 | |
| 18652326 | COMPOSITIONS COMPRISING PROBIOTIC AND POSTBIOTIC STRAINS OF BACTERIA | Iiaa Limited | STEPHENS, AMELIA CAROLE | 1645 | §101§102§103§112 | Non-Final OA | — | Pending | May 01, 2024 |
| 18287161 | SEALING ELEMENT ASSEMBLY FOR SHAFT SEAL | Sealway AB | BYRD, EUGENE G | 3675 | §103§112 | Non-Final OA | — | Pending | Oct 16, 2023 |
| 18373829 | SYSTEM AND METHODS TO ENHANCE CHEMOTHERAPY DELIVERY AND REDUCE TOXICITY | Sigyn Therapeutics | LEVY, BRANDON WILLIAM | 3781 | §103§112 | Non-Final OA | 61d | Pending | Sep 27, 2023 |
| 18277506 | VASCULAR OCCLUDER WITH INWARDLY INSERTABLE SEGMENT | Venacore Inc. | MCEVOY, THOMAS M | 3771 | §103§112 | Final Rejection | — | Pending | Aug 16, 2023 |
| 18232995 | Vector Transmitted Infectious Disease Assay | Tick Off, LLC | GRASER, JENNIFER E | 1645 | §103 | Non-Final OA | 8d | Pending | Aug 11, 2023 |
| 18202051 | COMPOSITIONS FOR A DIETARY SUPPLEMENT TO MANAGE SENESCENT CELLS | Qualia Life Sciences LLC | GONZALEZ, LUISALBERTO | 1624 | §102§103§112 | Non-Final OA | 13d | Pending | May 25, 2023 |
| 18135447 | SYSTEMS, DEVICES AND RELATED METHODS OF COORDINATING INSULIN MANAGEMENT AND DELIVERY MODES IN FASTING & NON-FASTING PERIODS | Luna Health, Inc. | OLYNICK, DAVID | 3741 | §112 | Non-Final OA | — | Pending | Apr 17, 2023 |
| 18032030 | VASCULAR ACCESS KIT | Embrace Medical Ltd. | MELHUS, BENJAMIN S | 3791 | §102§103 | Non-Final OA | 53d | Pending | Apr 14, 2023 |
| 18113598 | INTRASACULAR FLOW DIVERTER AND RELATED METHODS | NV Medtech, Inc. | KHANDKER, RAIHAN R | 3771 | §103 | Final Rejection | 27d | Pending | Feb 23, 2023 |
| 18014918 | SUBCUTANEOUS PORT FOR MINIMALLY INVASIVE IMPLANTATION | Portal Access, Inc. | ALLEN, ROBERT F | 3783 | §103§112 | Final Rejection | — | Pending | Jan 06, 2023 |
| 18077847 | INFUSION APPARATUS WITH INFECTION BARRIER | Portal Access Inc. | LALONDE, ALEXANDRA ELIZABETH | 3783 | §103§112 | Final Rejection | 28d | Pending | Dec 08, 2022 |
| 17922951 | MODIFIED LUPIN PROTEIN | Curtin University | KIM, BRYAN | 1792 | §103§112 | Final Rejection | — | Pending | Nov 02, 2022 |
| 17625637 | TOGGLING VASCULAR ACCESS PORT | Portal Access, Inc. | MARRISON, SAMUEL JOSEPH | 3783 | §102§103 | Non-Final OA | 22d overdue | Pending | Jan 07, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial